Literature DB >> 21531295

Development of a nano-zirconia based 68Ge/68Ga generator for biomedical applications.

Rubel Chakravarty1, Rakesh Shukla, Ramu Ram, Avesh Kumar Tyagi, Ashutosh Dash, Meera Venkatesh.   

Abstract

INTRODUCTION: Most of the commercially available (68)Ge/(68)Ga generator systems are not optimally designed for direct applications in a clinical context. We have developed a nano-zirconia based (68)Ge/(68)Ga generator system for accessing (68)Ga amenable for the preparation of radiopharmaceuticals.
METHODS: Nano-zirconia was synthesized by the in situ reaction of zirconyl chloride with ammonium hydroxide in alkaline medium. The physical characteristics of the material were studied by various analytical techniques. A 740 MBq (20 mCi) (68)Ge/(68)Ga generator was developed using this sorbent and its performance was evaluated for a period of 1 year. The suitability of (68)Ga for labeling biomolecules was ascertained by labeling DOTA-TATE with (68)Ga.
RESULTS: The material synthesized was nanocrystalline with average particle size of ~7 nm, pore-size of ~4 Å and a high surface area of 340±10 m(2) g(-1). (68)Ga could be regularly eluted from this generator in 0.01N HCl medium with an overall radiochemical yield >80% and with high radionuclidic (<10(-5)% of (68)Ge impurity) and chemical purity (<0.1 ppm of Zr, Fe and Mn ions). The compatibility of the product for preparation of (68)Ga-labeled DOTA-TATE under the optimized reaction conditions was found to be satisfactory in terms of high labeling yields (>99%). The generator gave a consistent performance with respect to the elution yield and purity of (68)Ga over a period of 1 year.
CONCLUSIONS: The feasibility of preparing an efficient (68)Ge/(68)Ga generator which can directly be used for biomedical applications has been demonstrated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531295     DOI: 10.1016/j.nucmedbio.2010.10.007

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  7 in total

Review 1.  Feasibility and availability of ⁶⁸Ga-labelled peptides.

Authors:  Clemens Decristoforo; Roger D Pickett; Alfons Verbruggen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 2.  68Ga-DOTA and analogs: Current status and future perspectives.

Authors:  Krzysztof Kilian
Journal:  Rep Pract Oncol Radiother       Date:  2014-05-19

Review 3.  Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.

Authors:  Marzia Marciello; Juan Pellico; Irene Fernandez-Barahona; Fernando Herranz; Jesus Ruiz-Cabello; Marco Filice
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

4.  Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging.

Authors:  Rubel Chakravarty; Hector F Valdovinos; Feng Chen; Christina M Lewis; Paul A Ellison; Haiming Luo; M Elizabeth Meyerand; Robert J Nickles; Weibo Cai
Journal:  Adv Mater       Date:  2014-06-18       Impact factor: 30.849

Review 5.  Prospective of ⁶⁸Ga-radiopharmaceutical development.

Authors:  Irina Velikyan
Journal:  Theranostics       Date:  2013-12-10       Impact factor: 11.556

Review 6.  Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging.

Authors:  Juan Pellico; Jordi Llop; Irene Fernández-Barahona; Riju Bhavesh; Jesús Ruiz-Cabello; Fernando Herranz
Journal:  Contrast Media Mol Imaging       Date:  2017-11-21       Impact factor: 3.161

7.  Characterization of SnO2-based (68)Ge/ (68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy.

Authors:  Ferdinand Sudbrock; Thomas Fischer; Beate Zimmermanns; Mehrab Guliyev; Markus Dietlein; Alexander Drzezga; Klaus Schomäcker
Journal:  EJNMMI Res       Date:  2014-07-24       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.